FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2049-2057 November 11, 2004 Number 20 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by Bloche, M. G. Editorial by Hare, J. M. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

ABSTRACT

Background We examined whether a fixed dose of both isosorbide dinitrate and hydralazine provides additional benefit in blacks with advanced heart failure, a subgroup previously noted to have a favorable response to this therapy.

Methods A total of 1050 black patients who had New York Heart Association class III or IV heart failure with dilated ventricles were randomly assigned to receive a fixed dose of isosorbide dinitrate plus hydralazine or placebo in addition to standard therapy for heart failure. The primary end point was a composite score made up of weighted values for death from any cause, a first hospitalization for heart failure, and change in the quality of life.

Results The study was terminated early owing to a significantly higher mortality rate in the placebo group than in the group given isosorbide dinitrate plus hydralazine (10.2 percent vs. 6.2 percent, P=0.02). The mean primary composite score was significantly better in the group given isosorbide dinitrate plus hydralazine than in the placebo group (–0.1±1.9 vs. –0.5±2.0, P=0.01; range of possible values, –6 to +2), as were its individual components (43 percent reduction in the rate of death from any cause [hazard ratio, 0.57; P=0.01] 33 percent relative reduction in the rate of first hospitalization for heart failure [16.4 percent vs. 22.4 percent, P=0.001], and an improvement in the quality of life [change in score, –5.6±20.6 vs. –2.7±21.2, with lower scores indicating better quality of life; P=0.02; range of possible values, 0 to 105]).

Conclusions The addition of a fixed dose of isosorbide dinitrate plus hydralazine to standard therapy for heart failure including neurohormonal blockers is efficacious and increases survival among black patients with advanced heart failure.

Source Information

From the University of Minnesota (A.L.T., J.N.C.) and Minneapolis Veterans Affairs Hospital (S.Z.) — both in Minneapolis; University of Texas Southwestern Medical Center, Dallas (C.Y.); Veterans Affairs Medical Center, Washington, D.C. (P.C.); Wake Forest University, School of Medicine, Winston-Salem, N.C. (R.D.); Heartbeats Life Center and Xavier University, New Orleans (K.F.); Jackson Cardiology Associates, Jackson, Miss. (M.T.); Association of Black Cardiologists, Atlanta (M.T.); University of North Carolina, Chapel Hill (K.A.); and NitroMed, Lexington, Mass. (M.S., M.W.).

Address reprint requests to Dr. Anne Taylor at the Department of Medicine/Cardiology, University of Minnesota Medical School, 420 Delaware St. SE, MMC 293, Minneapolis, MN 55455, or at taylo135{at}umn.edu.

Full Text of this Article

Related Letters:

Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Moran A. E., Cooper R. S., Fitzgibbons T. P., Chow A. Y., Bellin E. Y., Eisenberger A. B., Taylor A. L., Cohn J., Worcel M.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:1041-1043, Mar 10, 2005. Correspondence

This article has been cited by other articles:

• Boerrigter, G., Burnett, J. C. Jr (2009). Soluble Guanylate Cyclase: Not a Dull Enzyme. Circulation 119: 2752-2754 [Full Text]  
• Thomson, M. J., Frenneaux, M. P., Kaski, J. C. (2009). Antioxidant treatment for heart failure: friend or foe?. QJM 102: 305-310 [Abstract] [Full Text]  
• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]  
• Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]  
• 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]  
• 2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]  
• Dargie, H.J. (2009). Current controversies in drug use. Eur J Heart Fail Suppl 8: i15-i20 [Full Text]  
• Vassilev, Z. P., Chu, A. F., Ruck, B., Adams, E. H., Marcus, S. M. (2009). Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007. Am J Health Syst Pharm 66: 481-487 [Abstract] [Full Text]  
• Nicolini, F., Gherli, T. (2009). Alternatives to transplantation in the surgical therapy for heart failure. Eur. J. Cardiothorac. Surg. 35: 214-228 [Abstract] [Full Text]  
• Kamalesh, M. (2009). Diabetes and prognosis: are systolic and diastolic heart failure different?. Heart 95: 178-179 [Full Text]  
• Cheng, H.-M., Yu, W.-C., Sung, S.-H., Wang, K.-L., Chuang, S.-Y., Chen, C.-H. (2008). Usefulness of systolic time intervals in the identification of abnormal ventriculo-arterial coupling in stable heart failure patients. Eur J Heart Fail 10: 1192-1200 [Abstract] [Full Text]  
• Nieminen, M. S., Cleland, J. G.F., Eha, J., Belenkov, Y., Kivikko, M., Poder, P., Sarapohja, T. (2008). Oral levosimendan in patients with severe chronic heart failure--The PERSIST study. Eur J Heart Fail 10: 1246-1254 [Abstract] [Full Text]  
• Spertus, J. A. (2008). Evolving Applications for Patient-Centered Health Status Measures. Circulation 118: 2103-2110 [Abstract] [Full Text]  
• Guazzi, M. (2008). Clinical Use of Phosphodiesterase-5 Inhibitors in Chronic Heart Failure. Circ Heart Fail 1: 272-280 [Full Text]  
• Bahrami, H., Kronmal, R., Bluemke, D. A., Olson, J., Shea, S., Liu, K., Burke, G. L., Lima, J. A. C. (2008). Differences in the Incidence of Congestive Heart Failure by Ethnicity: The Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 168: 2138-2145 [Abstract] [Full Text]  
• Kahn, J. (2008). Exploiting race in drug development: BiDil's interim model of pharmacogenomics.. Social Studies of Science 38: 737-758 [Abstract]  
• Authors/Task Force Members, , Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Tendera, M., Auricchio, A., Bax, J., Bohm, M., Corra, U., della Bella, P., Elliott, P. M., Follath, F., Gheorghiade, M., Hasin, Y., Hernborg, A., Jaarsma, T., Komajda, M., Kornowski, R., Piepoli, M., Prendergast, B., Tavazzi, L., Vachiery, J.-L., Verheugt, F. W. A., Zamorano, J. L., Zannad, F. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29: 2388-2442 [Full Text]  
• Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989 [Full Text]  
• Ellison, G. T. H., Kaufman, J. S., Head, R. F., Martin, P. A., Kahn, J. D. (2008). Flaws in the U.S. Food and Drug Administration's Rationale for Supporting the Development and Approval of BiDil as a Treatment for Heart Failure Only in Black Patients.. J Law Med Ethics 36: 449-457  
• Ferdinand, K. C. (2008). Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?. J Law Med Ethics 36: 458-463  
• Gori, T., Parker, J. D. (2008). Nitrate-Induced Toxicity and Preconditioning: A Rationale for Reconsidering the Use of These Drugs. J Am Coll Cardiol 52: 251-254 [Abstract] [Full Text]  
• Mullens, W., Abrahams, Z., Francis, G. S., Skouri, H. N., Starling, R. C., Young, J. B., Taylor, D. O., Tang, W.H. W. (2008). Sodium nitroprusside for advanced low-output heart failure.. J Am Coll Cardiol 52: 200-207 [Abstract] [Full Text]  
• Cohn, J. N. (2008). Monitoring Adherence to Guidelines. Circ Heart Fail 1: 87-88 [Full Text]  
• Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Stough, W. G., Gheorghiade, M., Heywood, J. T., McBride, M. L., Mehra, M. R., O'Connor, C. M., Reynolds, D., Walsh, M. N. (2008). Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF. Circ Heart Fail 1: 98-106 [Abstract] [Full Text]  
• Ix, J. H., Allison, M. A., Denenberg, J. O., Cushman, M., Criqui, M. H. (2008). Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study.. J Am Coll Cardiol 51: 2347-2354 [Abstract] [Full Text]  
• Smart, A., Tutton, R., Martin, P., Ellison, G. T.H., Ashcroft, R. (2008). The standardization of race and ethnicity in biomedical science editorials and UK biobanks.. Social Studies of Science 38: 407-423 [Abstract]  
• Prisant, L. M., Thomas, K. L., Lewis, E. F., Huang, Z., Francis, G. S., Weaver, W. D., Pfeffer, M. A., McMurray, J. J.V., Califf, R. M., Velazquez, E. J. (2008). Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both. J Am Coll Cardiol 51: 1865-1871 [Abstract] [Full Text]  
• MacDonald, M. R., Petrie, M. C., Hawkins, N. M., Petrie, J. R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., McMurray, J. J.V. (2008). Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 29: 1224-1240 [Abstract] [Full Text]  
• Anand, I. S., Rector, T. S., Kuskowski, M., Thomas, S., Holwerda, N.J., Cohn, J. N. (2008). Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial. Circ Heart Fail 1: 34-42 [Abstract] [Full Text]  
• Yancy, C. W., Abraham, W. T., Albert, N. M., Clare, R., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., She, L., Sun, J. L., Young, J. B., Fonarow, G. C. (2008). Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry. J Am Coll Cardiol 51: 1675-1684 [Abstract] [Full Text]  
• Bourge, R. C., Abraham, W. T., Adamson, P. B., Aaron, M. F., Aranda, J. M. Jr, Magalski, A., Zile, M. R., Smith, A. L., Smart, F. W., O'Shaughnessy, M. A., Jessup, M. L., Sparks, B., Naftel, D. L., Stevenson, L. W., on behalf of the COMPASS-HF Study Group, (2008). Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.. J Am Coll Cardiol 51: 1073-1079 [Abstract] [Full Text]  
• Barnato, A. E., Alexander, S. L., Linde-Zwirble, W. T., Angus, D. C. (2008). Racial Variation in the Incidence, Care, and Outcomes of Severe Sepsis: Analysis of Population, Patient, and Hospital Characteristics. Am. J. Respir. Crit. Care Med. 177: 279-284 [Abstract] [Full Text]  
• Mata-Greenwood, E., Chen, D.-B. (2008). Racial Differences in Nitric Oxide--Dependent Vasorelaxation. Reproductive Sciences 15: 9-25 [Abstract]  
• Damasceno, A., Cotter, G., Dzudie, A., Sliwa, K., Mayosi, B. M. (2007). Heart Failure in Sub-Saharan Africa: Time for Action. J Am Coll Cardiol 50: 1688-1693 [Full Text]  
• Lewis, G. D., Shah, R., Shahzad, K., Camuso, J. M., Pappagianopoulos, P. P., Hung, J., Tawakol, A., Gerszten, R. E., Systrom, D. M., Bloch, K. D., Semigran, M. J. (2007). Sildenafil Improves Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension. Circulation 116: 1555-1562 [Abstract] [Full Text]  
• Shorr, A. F., Wainright, J. L., Cors, C. S., Lettieri, C. J., Nathan, S. D. (2007). Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 30: 715-721 [Abstract] [Full Text]  
• Davis, A. M., Vinci, L. M., Okwuosa, T. M., Chase, A. R., Huang, E. S. (2007). Cardiovascular Health Disparities: A Systematic Review of Health Care Interventions. Med Care Res Rev 64: 29S-100S [Abstract]  
• Tucker, C. M., Ferdinand, L. A., Mirsu-Paun, A., Herman, K. C., Delgado-Romero, E., van den Berg, J. J., Jones, J. D. (2007). The Roles of Counseling Psychologists in Reducing Health Disparities. The Counseling Psychologist 35: 650-678 [Abstract]  
• Pierce, R. O. Jr (2007). Ethnic and Racial Disparities in Diagnosis, Treatment, and Follow-up Care. J Am Acad Orthop Surg 15: S8-S12 [Abstract] [Full Text]  
• Williams, R. A. (2007). Cultural Diversity, Health Care Disparities, and Cultural Competency in American Medicine. J Am Acad Orthop Surg 15: S52-S58 [Abstract] [Full Text]  
• Cohn, J. N. (2007). Myocardial Structural Effects of Aldosterone Receptor Antagonism in Heart Failure. J Am Coll Cardiol 50: 597-599 [Full Text]  
• Hagos, G. K., Carroll, R. E., Kouznetsova, T., Li, Q., Toader, V., Fernandez, P. A., Swanson, S. M., Thatcher, G. R.J. (2007). Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivo. Molecular Cancer Therapeutics 6: 2230-2239 [Abstract] [Full Text]  
• Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S. (2007). REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Hypertension 50: e28-e55 [Full Text]  
• Kreimer, S. (2007). BiDil Not Widely Prescribed. DOC News 4: 23-23 [Full Text]  
• Moni, R. W., Hryciw, D. H., Poronnik, P., Moni, K. B. (2007). Using explicit teaching to improve how bioscience students write to the lay public. Adv. Physiol. Educ. 31: 167-175 [Abstract] [Full Text]  
• Metra, M., Ponikowski, P., Dickstein, K., McMurray, J. J.V., Gavazzi, A., Bergh, C.-H., Fraser, A. G., Jaarsma, T., Pitsis, A., Mohacsi, P., Bohm, M., Anker, S., Dargie, H., Brutsaert, D., Komajda, M., on behalf of the Heart Failure Association of the, (2007). Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 9: 684-694 [Abstract] [Full Text]  
• Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S. (2007). Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115: 2761-2788 [Full Text]  
• Friedrich, E. B, Bohm, M. (2007). MANAGEMENT OF END STAGE HEART FAILURE. Heart 93: 626-631 [Full Text]  
• Munzel, T., Genth-Zotz, S., Hink, U. (2007). Targeting Heme-Oxidized Soluble Guanylate Cyclase: Solution for All Cardiorenal Problems in Heart Failure?. Hypertension 49: 974-976 [Full Text]  
• Frazier, C. G., Alexander, K. P., Newby, L. K., Anderson, S., Iverson, E., Packer, M., Cohn, J., Goldstein, S., Douglas, P. S. (2007). Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction: A Pooled Analysis of 5 Randomized Control Trials. J Am Coll Cardiol 49: 1450-1458 [Abstract] [Full Text]  
• Taylor, A. L., Ziesche, S., Yancy, C. W., Carson, P., Ferdinand, K., Taylor, M., Adams, K., Olukotun, A. Y., Ofili, E., Tam, S. W., Sabolinski, M. L., Worcel, M., Cohn, J. N., on behalf of the African-American Heart Failure Tr, (2007). Early and Sustained Benefit on Event-Free Survival and Heart Failure Hospitalization From Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine: Consistency Across Subgroups in the African-American Heart Failure Trial. Circulation 115: 1747-1753 [Abstract] [Full Text]  
• Thomas, G. R., DiFabio, J. M., Gori, T., Parker, J. D. (2007). Once Daily Therapy With Isosorbide-5-Mononitrate Causes Endothelial Dysfunction in Humans: Evidence of a Free-Radical-Mediated Mechanism. J Am Coll Cardiol 49: 1289-1295 [Abstract] [Full Text]  
• Allen, L. A., O'Connor, C. M. (2007). Management of acute decompensated heart failure. CMAJ 176: 797-805 [Abstract] [Full Text]  
• Wu, A. H (2007). Management of patients with non-ischaemic cardiomyopathy. Heart 93: 403-408 [Full Text]  
• Anand, I. S., Tam, S. W., Rector, T. S., Taylor, A. L., Sabolinski, M. L., Archambault, W. T., Adams, K. F., Olukotun, A. Y., Worcel, M., Cohn, J. N. (2007). Influence of Blood Pressure on the Effectiveness of a Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in the African-American Heart Failure Trial. J Am Coll Cardiol 49: 32-39 [Abstract] [Full Text]  
• Pfeffer, M. A. (2007). Blood Pressure in Heart Failure: A Love-Hate Relationship. J Am Coll Cardiol 49: 40-42 [Full Text]  
• Bibbins-Domingo, K., Fernandez, A. (2007). BiDil for Heart Failure in Black Patients: Implications of the U.S. Food and Drug Administration Approval. ANN INTERN MED 146: 52-56 [Abstract] [Full Text]  
• Temple, R., Stockbridge, N. L. (2007). BiDil for Heart Failure in Black Patients: The U.S. Food and Drug Administration Perspective. ANN INTERN MED 146: 57-62 [Abstract] [Full Text]  
• Weisfeldt, M. L., Zieman, S. J. (2007). Advances In The Prevention And Treatment Of Cardiovascular Disease. Health Aff (Millwood) 26: 25-37 [Abstract] [Full Text]  
• Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]  
• Greenberg, B., Mehra, M. R. (2006). All Patients With Heart Failure and Intraventricular Conduction Defect or Dyssynchrony Should Not Receive Cardiac Resynchronization Therapy. Circulation 114: 2685-2691 [Full Text]  
• Taylor, A. L., Lindenfeld, J., Ziesche, S., Walsh, M. N., Mitchell, J. E., Adams, K., Tam, S. W., Ofili, E., Sabolinski, M. L., Worcel, M., Cohn, J. N., for the A-HeFT Investigators, (2006). Outcomes by Gender in the African-American Heart Failure Trial. J Am Coll Cardiol 48: 2263-2267 [Abstract] [Full Text]  
• Kilbourne, A. M., Switzer, G., Hyman, K., Crowley-Matoka, M., Fine, M. J. (2006). Advancing Health Disparities Research Within the Health Care System: A Conceptual Framework. Am. J. Public Health 96: 2113-2121 [Abstract] [Full Text]  
• Ibrahim, S. A., Stone, R. A., Obrosky, D. S., Sartorius, J., Fine, M. J., Aujesky, D. (2006). Racial Differences in 30-Day Mortality for Pulmonary Embolism. Am. J. Public Health 96: 2161-2164 [Abstract] [Full Text]  
• Brewster, L. M., Mairuhu, G., Bindraban, N. R., Koopmans, R. P., Clark, J. F., van Montfrans, G. A. (2006). Creatine Kinase Activity Is Associated With Blood Pressure. Circulation 114: 2034-2039 [Abstract] [Full Text]  
• Brody, H., Hunt, L. M. (2006). BiDil: Assessing a Race-Based Pharmaceutical. Ann Fam Med 4: 556-560 [Abstract] [Full Text]  
• Donahue, M. P., Marchuk, D. A., Rockman, H. A. (2006). Redefining Heart Failure: The Utility of Genomics. J Am Coll Cardiol 48: 1289-1298 [Abstract] [Full Text]  
• Zimmet, J. M., Hare, J. M. (2006). Nitroso-Redox Interactions in the Cardiovascular System. Circulation 114: 1531-1544 [Full Text]  
• McNamara, D. M., Tam, S. W., Sabolinski, M. L., Tobelmann, P., Janosko, K., Taylor, A. L., Cohn, J. N., Feldman, A. M., Worcel, M. (2006). Aldosterone Synthase Promoter Polymorphism Predicts Outcome in African Americans With Heart Failure: Results From the A-HeFT Trial. J Am Coll Cardiol 48: 1277-1282 [Abstract] [Full Text]  
• Gheorghiade, M., Sopko, G., De Luca, L., Velazquez, E. J., Parker, J. D., Binkley, P. F., Sadowski, Z., Golba, K. S., Prior, D. L., Rouleau, J. L., Bonow, R. O. (2006). Navigating the Crossroads of Coronary Artery Disease and Heart Failure. Circulation 114: 1202-1213 [Full Text]  
• Lillquist, E., Sullivan, C. A. (2006). Legal Regulation of the Use of Race in Medical Research. J Law Med Ethics 34: 535-551  
• Cohn, J. N. (2006). The Use of Race and Ethnicity in Medicine: Lessons from the African-American Heart Failure Trial. J Law Med Ethics 34: 552-554  
• Groban, L., Butterworth, J. (2006). Perioperative management of chronic heart failure.. Anesth. Analg. 103: 557-575 [Abstract] [Full Text]  
• Howard, P. A, Cheng, J. W., Crouch, M. A, Colucci, V. J, Kalus, J. S, Spinler, S. A, Munger, M. (2006). Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure. The Annals of Pharmacotherapy 40: 1607-1616 [Abstract] [Full Text]  
• Puckrein, G. (2006). BiDil: From Another Vantage Point. Health Aff (Millwood) 25: w368-w374 [Abstract] [Full Text]  
• Kahn, J., Sankar, P. (2006). Being Specific About Race-Specific Medicine. Health Aff (Millwood) 25: w375-w377 [Abstract] [Full Text]  
• Bourque, J. M., O'Connor, C. M., Velazquez, E. J. (2006). Letter by Bourque et al Regarding Article, "Changing Incidence and Survival for Heart Failure in a Well-Defined Older Population, 1970-1974 and 1990-1994". Circulation 114: e255-e255 [Full Text]  
• Granger, C. B., McMurray, J. J.V. (2006). Using Measures of Disease Progression to Determine Therapeutic Effect: A Sirens' Song. J Am Coll Cardiol 48: 434-437 [Abstract] [Full Text]  
• Cohn, J. N. (2006). Efficacy and Safety in Clinical Trials in Cardiovascular Disease. J Am Coll Cardiol 48: 430-433 [Abstract] [Full Text]  
• McMurray, J., Swedberg, K. (2006). Treatment of chronic heart failure: a comparison between the major guidelines. Eur Heart J 27: 1773-1777 [Abstract] [Full Text]